TY - JOUR
T1 - Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
AU - Knol, Mirjam J.
AU - Ruijs, Wilhelmina L. M.
AU - Antonise-Kamp, Laura
AU - de Melker, Hester E.
AU - van der Ende, Arie
PY - 2018
Y1 - 2018
N2 - The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.
AB - The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045879597&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29692317
U2 - https://doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158
DO - https://doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158
M3 - Article
C2 - 29692317
SN - 1025-496X
VL - 23
JO - Euro surveillance
JF - Euro surveillance
IS - 16
M1 - 18-00158
ER -